The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery-Reference-Cited by-同舟云学术

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery

Published:2014-08-02 Issue:7 Volume:110 Page:779-785
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Prada-Villaverde Arancha¹,Esquivel Jesus²,Lowy Andrew M.³,Markman Maurie⁴,Chua Terence⁵,Pelz Joerg⁶,Baratti Dario⁷,Baumgartner Joel M.³,Berri Richard⁸,Bretcha-Boix Pedro⁹,Deraco Marcello⁷,Flores-Ayala Guillermo¹⁰,Glehen Olivier¹¹,Gomez-Portilla Alberto¹²,González-Moreno Santiago¹³,Goodman Martin¹⁴,Halkia Evgenia¹⁵,Kusamura Shigeki⁷,Moller Mecker¹⁶,Passot Guillaume¹¹,Pocard Marc¹⁷,Salti George¹⁸,Sardi Armando¹⁹,Senthil Maheswari²⁰,Spiliotis John¹⁵,Torres-Melero Juan²¹,Turaga Kiran²²,Trout Richard²³

Affiliation:

1. Deaprtment of General Surgery; Hospital Infanta Cristina; Cordoba Spain

2. Department of Surgical Oncology; Cancer Treatment Centers of America; Philadelphia Pennsylvania

3. Division of Surgical Oncology; Moores Cancer Center; University of California; San Diego California

4. Department of Medical Oncology; Cancer Treatment Centers of America; Philadelphia Pennsylvania

5. Hepatobiliary and Surgical Oncology Unit; St. George Hospital; Sydney NSW Australia

6. Department of Surgery; University of Wuerzburg; Wuerzburg Germany

7. Department of Surgery; National Cancer Institute; Milan Italy

8. Department of Surgical Oncology; St John Hospital; Detroit Michigan

9. General Surgery Service; Hospital San Jaime; Alicante Spain

10. Department of Surgical Oncology; Instituto Jalisciense de Cancerologia; Guadalajara Mexico

11. Department of Surgical Oncology; Centre Hospitalier Lyon-Sud; Pierre-Benite France

12. Department of Surgery; San Jose Hospital; Vitoria Spain

13. Department of Surgical Oncology; MD Anderson Cancer Center; Madrid Spain

14. Department of Surgical Oncology; Tufts Medical Center; Boston Massachusetts

15. Department of Gynecology; Metaxa Cancer Memorial Hospital; Pireus Greece

16. Department of Surgical Oncology; University of Miami; Miami Florida

17. Department of Surgery; Hospital Lariboisiere; Paris France

18. Department of Surgical Oncology; University of Illinois; Champaign Illinois

19. Department of Surgical Oncology; Mercy Medical Center; Baltimore Maryland

20. Department of Surgical Oncology; Loma Linda University Medical Center; Loma Linda California

21. Department of Surgical Oncology; Hospital Torrecardenas; Almeria Spain

22. Department of Surgery; Medical College of Wisconsin; Milwaukee Wisconsin

23. Professor Emeritus; Department of Statistics; Rutgers University; New Brunswick New Jersey

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference15 articles.

1. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma;Elias;Surg Oncol Clin N Am,2012

2. Peritoneal carcinomatosis: Cytoreductive surgery and HIPEC-overview and basic;Brücher;Cancer Invest,2012

3. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan and Korea;Esquivel;Cancer J,2009

4. The American Society of Peritoneal Surface Malignancies (ASPSM);Esquivel;Ann Surg Oncol,2011

5. Consensus guidelines from the american society of peritoneal surface malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States;Turaga;Ann Surg Oncol,2014

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers;Annals of Surgical Oncology;2024-01-04

2. 2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer;Annals of Surgical Oncology;2023-11-08

3. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan;International Journal of Surgery;2023-10-05

4. Evolving role of cytoreduction and HIPEC for colorectal cancer;Seminars in Colon and Rectal Surgery;2023-09

5. Meeting actual benchmarks for short- and long-term outcomes after cytoreductive surgery for peritoneal surface malignancy at a newly established academic treatment center;Surgery;2023-08